Skip to main content
FinSpry Logo
FinSpry
G
GENB
(NASDAQ)
Generate Biomedicines, Inc.
$12.42-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Generate Biomedicines (GENB) Income Statement

Revenue, expenses, profit margins, and earnings with annual and quarterly data.

Generate Biomedicines Income Statement Analysis

Revenue, earnings, and profit margins in millions USD

Income StatementBalance SheetCash FlowRatios
Scroll to see more
Generate Biomedicines, Inc. income statement - Annual data in millions USD
BreakdownFY 2025FY 2024
Period EndingDec 2025Dec 2024
Revenue & Gross Profit
Revenue31.8920.46
Cost of Revenue0.000.00
Gross Profit31.8920.46
Operating Expenses
Research & Development224.70175.31
Selling, General & Administrative42.2642.09
Operating Expenses266.96217.40
Operating Income-235.07-196.94
Other Income/Expense
Interest Income13.6618.12
Interest Expense1.142.12
Other Income/Expense-0.26-0.23
Income
Income Before Tax-222.80-181.17
Income Tax Expense0.160.21
Net Income-203.15-173.77
Net Income - Continuous Operations-222.97-181.38
Net Income - Discontinued Operations0.000.00
EBITDA-208.49-163.71
EBIT-221.67-179.05
Depreciation & Amortization13.1815.35
Earnings Per Share
Basic EPS-8.00-2.00
Diluted EPS-8.00-2.00
Basic Shares Outstanding32.97102.31
Diluted Shares Outstanding32.97102.31

Metrics Derived from the Income Statement

These financial metrics are calculated using income statement data. Learn how each metric works and screen stocks by them.

Revenue

Total sales generated from business operations

Earnings Per Share (EPS)

Net income allocated to each outstanding share

Gross Margin

Revenue remaining after cost of goods sold

Operating (EBIT) Margin

Profitability from core operations before interest and taxes

Net Profit Margin

Percentage of revenue retained as profit after all expenses

EBITDA

Earnings before interest, taxes, depreciation, and amortization

View Generate Biomedicines Ratios →Screen Stocks by Profitability →